Skip to main content

Drug safety disclosures

Matrixx Initiatives v. Siracusano

Updated Oct 18, 2026

In brief

The Supreme Court agreed that the investors had stated a claim against Matrixx, leaving the appeals court’s ruling in place.

Where it stands
Decided

Decided · March 22, 2011 · Opinion by Justice Sotomayor

What it’s about
Investors accused Matrixx Initiatives of misleading them by not disclosing reports and lawsuits linking its Zicam products to loss of smell, although the reports were not statistically significant.
Who it affects
These investors can pursue their claim against Matrixx, but the ruling does not establish that the company was liable.

Summary: written with AI from the case record.

Illustration for Matrixx Initiatives, Inc. v. James Siracusano
Conceptual illustration · AI-generated

What it's about

The Supreme Court agreed with the appeals court that the investors had alleged enough to bring a securities-fraud claim: reports need not be statistically significant to be important to investors.

The reports involved Matrixx’s Zicam products and loss of smell; the investors did not allege that the reports were statistically significant.

The dispute concerned what investors must allege when they claim a drug company hid information about possible side effects.

Question presented

Can a plaintiff state a claim under the Securities Exchange Act based on a pharmaceutical company's non-disclosure of adverse event reports even though the reports are not alleged to be statistically significant?

What the Court decided

Holding

Respondents have stated a claim under §10(b) and Rule 10b–5. 585 F. 3d 1167, affirmed.

Result
Affirmed

The vote

Majority author
Sonia Sotomayor

What's next

The investors’ claim may continue in the lower courts. The ruling did not decide whether Matrixx ultimately violated the law.

Documents

2

Docket activity

10
  • New analysis added

    Oct 18, 2026 · Court records

  • AI analysis generated: Impact Analysis

    Oct 18, 2026 · Generated

  • AI analysis generated: Opinion Summary

    Oct 18, 2026 · Generated

  • New analysis added

    Oct 18, 2026 · Court records

  • AI analysis generated: Case Briefing

    Oct 18, 2026 · Generated

Show 5 more
  • AI analysis generated: Decision Record

    Oct 18, 2026 · Generated

  • Case data updated: summary, question_presented, generation_metadata

    Oct 18, 2026 · Court records

  • Case data updated: question_presented, extraction_metadata

    Oct 17, 2026 · Court records

  • Audio Recording added: Oral Arguments - Siracusano

    Oct 30, 2014 · Court records

  • Opinion added: Siracusano

    Mar 22, 2011 · Court records

Sources

Primary materials plus reporting. Best-effort analysis: this explainer relies on a mix of primary materials and trusted secondary sources. Official filings and opinions remain authoritative.

Checked Oct 18, 2026Methodology

Court records and filings

Reporting and analysis